Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 20/20 | 0.73 |
| ▸ | PRSS1 | P07477 | 10/20 | 0.73 |
| ▸ | PLG | P00747 | 1/20 | 0.60 |
| ▸ | PROC | P04070 | 1/20 | 0.60 |
| ▸ | PRSS2 | P07478 | 2/20 | 0.58 |
| ▸ | PRSS3 | P35030 | 2/20 | 0.58 |
| ▸ | F2 | P00734 | 2/20 | 0.57 |
| ▸ | F9 | P00740 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6297021 | 0.92 | F10 (0.65) | F10PRSS1PLGPROCPRSS2 | |
| SCHEMBL7597733 | 0.90 | F10 (0.73) | F10PRSS1PLGPROCPRSS2 | |
| SCHEMBL7599312 | 0.88 | F10 (0.71) | F10PRSS1PLGPROCPRSS2 | |
| SCHEMBL7596363 | 0.87 | F10 (0.70) | F10PRSS1PLGPROCPRSS2 | |
| SCHEMBL7600812 | 0.87 | F10 (0.72) | F10PRSS1PLGPROCPRSS2 | |
| SCHEMBL7118516 | 0.85 | F10 (1.00) | F10PRSS1PLGPROCPRSS2 | |
| SCHEMBL7006420 | 0.82 | F10 (0.65) | F10PRSS1PRSS2PRSS3F2 | |
| SCHEMBL7007614 | 0.82 | F10 (0.65) | F10PRSS1PRSS2PRSS3F2 | |
| SCHEMBL7005930 | 0.82 | F10 (0.63) | F10PRSS1PRSS2PRSS3F2 | |
| SCHEMBL7119942 | 0.82 | F10 (0.75) | F10PRSS1PLGPROC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030135055-A1 | Aminosulfonylbiphenyl derivatives | MERCK PATENT GMBH (DE) | 2003-07-17 | — | — | US | claimed |
| US-20030135055-A1 | Aminosulfonylbiphenyl derivatives | MERCK PATENT GMBH (DE) | 2003-07-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030135055-A1 | Aminosulfonylbiphenyl derivatives | APOB, F12, SERPINB1 | F10 60/4885PRSS1 34/4885PLG 58/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.